Ogilvy Health CEO Kate Cronin will join COVID-19 vaccine maker Moderna as chief brand officer on July 12. She will report to CEO Stéphane Bancel.
At Ogilvy, Cronin led PR, social, brand and digital campaigns for clients such as Pfizer, Merck, BMS and Boehringer Ingelheim.
She has been involved with brand strategy, advertising, patient & consumer engagement, medical education, medical devices and market access issues.
Prior to assuming the top Ogilvy Health spot, Cronin was global managing director of Ogilvy PR’s New York outpost.
Cronin will move to Moderna after a 17-year Ogilvy career and a 13-year stint at Porter Novelli, where she exited as partner.
Bancel praised Cronin’s “creativity and digital-first mindset to create integrated best-in-class campaigns for global commercial biopharmaceutical companies.”
Powered by the sale of the COVID-19 vaccine, Moderna recorded $1.9B in Q1 revenues vs. $8M for the year ago period. It earned $1.3B in Q1 `21 compared to a $124M `20 Q1 loss.